HIV Vaccine Trials Network
Jump to navigation
Jump to search
The HIV Vaccine Trials Network is a collaboration between physicians, scientists and activists that conducts clinical trials seeking a safe and effective HIV vaccine. They review potential vaccines for safety, immune response and efficacy. The HVTN is currently involved in seventeen vaccine trials. They are supported by the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health. They are headquartered at the Fred Hutchinson Cancer Research Center in Seattle. The HVTN has started the first large scale HIV vaccine trials in Africa, with financial assistance from SA Aids Vaccine Initiative. This study will last four years and include up to 3000 participants.[1][2]
References
- ↑ "Africa's First Large-Scale HIV Vaccine Study Launches". Medical News Today date=2007-02-09. Retrieved 2007-03-08.
- ↑ "Volunteers join HIV vaccine trial". IOL. Retrieved 2007-03-08.